Skip Navigation
  • Text Size: A A A
  • Print
  • Email
  • Facebook
  • Tweet
  • Share

National Vaccine Program Office

National Vaccine Advisory Committee
Hubert H. Humphrey Building, Rm. 800
February 3-4, 2004

NVAC Chair Summary of Meeting [DOC - 34k]

Minutes [DOC - 173KB]

Draft Agenda
(as of February 2, 2004)

Tuesday, February 3

9:00

Opening Session
Introduction
Approval of Minutes from October Meeting
Report of the Chair

Dr. Peter

9:15

Report from the NVPO

Dr. Gellin

9:25

Welcome from the Acting Assistant Secretary for Health

Dr. Beato

Influenza 2003-2004: Review and Lessons Learned for Next Year and the Future

9:30

The Current Season: Virus/Disease/Vaccine & Efficacy

Dr. Cox

9:50

Vaccine strain selection process and regulatory issues

Dr. Weir

10:10

Public Perception of Influenza/Influenza Vaccine

Dr. Nowak

10:30

Discussion

Dr. Peter

10:45

Break

 

Perspectives of Influenza Vaccine Manufacturers

11:00

AventisPasteur

Ms. Grant

11:15

Chiron

Dr. Lewin

11:30

MedImmune/Wyeth

Dr. Paradiso

11:45

Baxter

Dr. Fusco

12:00

Discussion and Public Comment

Dr. Peter

12:30

Lunch

 

Influenza—continued

1:30

Public sector roles in adult and childhood influenza vaccination

Dr. Rodewald

1:45

CMS: Financing and Quality Improvement Organizations Efforts

Dr. Farris

2:00

Perspective of Health Plans and Insurers

Mr. Rehm

2:15

Influenza Vaccine R&D Toward a “Better” Vaccine

Dr. Cassetti

2:30

Pandemic Influenza Preparedness

Dr. Schwartz

2:45

Discussion and Public Comment

 

3:00

Next Steps

Dr. Peter

3:30

Subcommittee Meetings
Subcommittee on Future Vaccines - Room 405A
Subcommittee on Vaccine Safety and Communication - Room 425A
Subcommittee on Immunization Coverage - Room 800

 

 

Wednesday, February 4

Working Group Updates and Reports

8:30

Polio Laboratory Containment, Phase 1: FINAL REPORT
Discussion

Dr. Arvin/Dr. Dowdle

9:00

Polio Vaccine Stockpile
Discussion

Dr. Helms/Dr. Alexander

9:30

Public Participation in Vaccine Decision Making
Discussion

Ms. Katz

9:45

Public Health Options for Implementing Vaccine Recommendations
Discussion

Dr. Williamson/Dr Santoli

10:45

Break

 

11:00

Vaccine Financing
Discussion

Dr. Hinman/Dr. Smith

11:15

DMSS Working Group on Anthrax Vaccine Safety
Discussion

Dr. Davis/Dr. McNeil

Subcommittee Updates and Reports

11:30

Immunization Coverage Subcommittee
Discussion

Dr. Whitley-Williams

11:45

Future Vaccines Subcommittee
Discussion

Dr. Fast

12:00

Vaccine Safety and Communication Subcommittee
Discussion

Dr. Klein

12:15

Lunch

 

1:00

Vaccine Management Business Improvement Project
Discussion

Ms. Lane

1:15

Project BioShield

Dr. Russell

Thimerosal/Autism Litigation

1:30

Vaccine Injury Compensation Program

Ms. Saindon

1:50

Civil Litigation - Update

Mr. Moss

2:10

Discussion

 

HHS Agencies/Committees Reports

2:20

ACCV/DVIC Report

Ms. Noyes/Dr. Evans

2:30

VRPBAC/FDA Report

Dr. Overturf/Dr. Baylor

2:40

ACIP/NIP Report

Dr. Cochi

2:50

NIH

Dr. Curlin

3:00

Public Comment

 

3:15

Adjourn